Xueming Wu
Impact in
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Phytochemicals and Antioxidant Activities 4
- Co-authors
- Zheng‐Rong LuHiroaki TodoMingqian TanKenji SugibayashiEun‐Kee JeongRen Xiang TanBingfang HeJianlin Chu
- Journals
- RSC Advances (4 papers)Pharmaceutical Research (4 papers)Molecular Pharmaceutics (3 papers)Bioconjugate Chemistry (2 papers)Japanese Journal of Applied Physics (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xueming Wu
58 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 104
- Pharmaceutical Science 171
- Biomaterials 178
- Biotechnology 86
- Dermatology 85
- Molecular Biology 654
Countries citing papers authored by Xueming Wu
This map shows the geographic impact of Xueming Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueming Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueming Wu more than expected).
Fields of papers citing papers by Xueming Wu
This network shows the impact of papers produced by Xueming Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueming Wu. The network helps show where Xueming Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xueming Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 10 | |
| 6 | 2022 | 19 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 4 | |
| 9 | 2020 | 8 | |
| 10 | 2019 | 32 | |
| 11 | 2018 | 138 | |
| 12 | 2018 | 76 | |
| 13 | 2017 | 94 | |
| 14 | 2013 | 10 | |
| 15 | 2012 | 44 | |
| 16 | 2012 | 27 | |
| 17 | 2010 | 20 | |
| 18 | 2006 | 96 | |
| 19 | 2006 | 37 | |
| 20 | 2004 | 43 |
About Xueming Wu
Xueming Wu is a scholar working on Pharmaceutical Science, Biochemistry, Radiology, Nuclear Medicine and Imaging, Biotechnology and Biomaterials, having authored 61 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lanthanide and Transition Metal Complexes (13 papers), Advanced MRI Techniques and Applications (8 papers), MRI in cancer diagnosis (7 papers), Nanoparticle-Based Drug Delivery (6 papers), Microbial Natural Products and Biosynthesis (4 papers), Phytochemicals and Antioxidant Activities (4 papers), Fermentation and Sensory Analysis (4 papers) and Natural product bioactivities and synthesis (3 papers). The work is most often cited by research in Pharmaceutical Science (171 citations), Biomaterials (178 citations), Biotechnology (86 citations), Dermatology (85 citations) and Molecular Biology (654 citations). Xueming Wu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Zheng‐Rong Lu, Hiroaki Todo, Mingqian Tan, Kenji Sugibayashi, Eun‐Kee Jeong, Ren Xiang Tan, Bingfang He, Jianlin Chu, Dennis L. Parker and Randy L. Jensen. Their work appears in journals such as RSC Advances, Pharmaceutical Research, Molecular Pharmaceutics, Bioconjugate Chemistry and Japanese Journal of Applied Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.